Biohaven (BHVN) is presented as a top conviction holding, representing a core long position with significant potential. For long-term exposure to the Artificial Intelligence (AI) theme, consider accumulating shares of Palantir (PLTR), especially on price dips. On the bearish side, Capricorn Therapeutics (CAPR) is identified as a high-conviction short opportunity based on a belief that its science is flawed. Similarly, consider betting against quantum computing company IonQ (IONQ), which is viewed as an overvalued and potentially fraudulent company. Lastly, Duolingo (DUOL) is highlighted as a new long position due to its strong financial growth and potential as an acquisition target.

Palantir (PLTR)

• The speaker is long-term bullish on Palantir, viewing it as a crucial way to get exposure to the Artificial Intelligence (AI) trend, which he calls "the biggest trend in history."
• He mentions buying the stock as a "hedge" against his bearish bets on quantum computing companies.
• He expresses trust in the CEO, Alex Karp, and believes that major institutional investors ("the guys in Boston") will continue to buy the stock for AI exposure, causing it to "always recover" from dips.
• During the stream, he repeatedly buys more shares of PLTR as the price drops.
• Highly Speculative Trade: The speaker engages in a very high-risk trade by purchasing a large number of out-of-the-money $180 call options that expire the next day. This is an extremely risky gamble on a sharp, immediate price increase. He refers to this as "degenerate" and "stupid," acknowledging it was done partly for "boredom" and entertainment.

Takeaways

• Long-Term Bullish: The speaker sees Palantir as a core holding for AI exposure and believes in its long-term recovery and growth potential. He is confident buying the stock on weakness.
• Short-Term Volatility: The stock is shown to be very volatile. The speaker's purchase of short-dated call options is a pure gamble and should not be replicated by most investors. It highlights the potential for massive gains or, more likely, a total loss of the capital invested in the options.
• Key Drivers: The investment thesis is based on the continued growth of the AI sector and the belief that large funds will need to own PLTR for exposure.

Quantum Computing: IonQ (IONQ) & D-Wave (QBTS)

• The speaker expressed a strong bearish (negative) sentiment towards the quantum computing sector, specifically mentioning IonQ and D-Wave.
• IonQ (IONQ): He is actively shorting the stock, calling it a "worthless, fraudulent company." He is skeptical of their revenue reporting, suggesting they hide how much is coming from acquired businesses versus organic growth.
• D-Wave (QBTS): He mentioned that D-Wave beat earnings but he remains bearish, calling the stock "garbage." He holds put options on the company, which is a bet that the stock price will go down. He was surprised to find he was accidentally long 1,000 shares and immediately sold them.

Takeaways

• Bearish Thesis: The speaker believes quantum computing stocks like IONQ and QBTS are overvalued and potentially fraudulent. He is betting on their prices to fall significantly.
• Action: His strategy involves short-selling the stocks or buying put options. This is a high-risk strategy intended for experienced investors who believe a stock's price will decrease.
• Risk Factor Mentioned: For IonQ, the speaker specifically questions the transparency of their revenue sources, which he sees as a major red flag.

Duolingo (DUOL)

• The speaker's opinion on Duolingo evolved during the stream. He initially called it a "meme" stock that was "getting crushed."
• After looking at their earnings, he noted they "beat my numbers" and that he "always like[s] the financials."
• He is conflicted because while the numbers look good, he has heard from "really smart money" that it's a "toxic situation" and problematic, comparing it to Carvana.
• Despite the warnings, he decides to "go long" Duolingo, selling a portion of his Palantir holdings to fund the purchase. He sees it as an "application" that is hard to replicate, even with powerful AI tools.
• He speculates that a company like OpenAI could potentially acquire Duolingo for its distribution and user base.

Takeaways

• Conflicted but Bullish: The speaker is intrigued by Duolingo's strong financial performance and growth, leading him to buy the stock despite hearing negative sentiment from other investors.
• Competitive Moat: The insight is that having a popular application with a large user base (distribution) is a significant advantage that is difficult for even a powerful AI company to build from scratch.
• Potential Catalyst: A potential acquisition by a larger tech company like OpenAI is mentioned as a possibility.

Biohaven (BHVN)

• The speaker is very bullish (positive) on Biohaven, stating it is his "biggest position."
• He mentioned buying the stock "yesterday" and expressed some impatience for it to move higher but remains committed to the position.
• He is holding the stock through a market downturn, indicating strong conviction in the company.

Takeaways

• High Conviction Bull: Biohaven is the speaker's largest and most confidently held long position.
• Strategy: This appears to be a core holding for the speaker, suggesting a belief in the company's fundamental value or upcoming catalysts, rather than a short-term trade.

Capricorn Therapeutics (CAPR)

• The speaker is extremely bearish (negative) on Capricorn Therapeutics.
• He explicitly calls it a "short" and advises to "sell it all."
• He heavily mocks the company's science, comparing their cell therapy approach to a caveman's primitive ritual, suggesting he believes it is nonsensical.

Takeaways

• Strong Sell/Short Recommendation: This is one of the speaker's strongest negative calls. He believes the company's scientific premise is flawed and the stock is a compelling short-selling opportunity.
• Risk: The speaker's criticism is focused entirely on his disbelief in the underlying science of the company's therapy.

Eli Lilly (LLY)

• The speaker was very impressed by new data from an Eli Lilly weight-loss drug, which reportedly showed 20% weight loss.
• He described the result as "powerful" and speculated on its potential.
• He believes that combining this new drug with existing GLP-1 therapies would be revolutionary, stating "you're going to disappear. You're never going to be a fat person again."

Takeaways

• Bullish on Innovation: The speaker is highly optimistic about the potential of Eli Lilly's new weight loss drug.
• Combination Therapy: The key insight is the potential for this new mechanism to be combined with the popular GLP-1 drugs, creating an even more effective treatment and a massive market opportunity.

Sarepta Therapeutics (SRPT)

• The speaker refers to the company as "syrup" and confirms he is long the stock ("long syrup").
• He mentioned that he sold some shares on a recent bounce, indicating an active trading approach to the position.
• The stock is mentioned multiple times with a generally positive tone.

Takeaways

• Bullish but Trading-Oriented: The speaker is positive on Sarepta but is also actively trading around his position, taking profits on strength. This suggests he sees continued upside but is also managing his risk and realizing gains along the way.